Beckman Coulter Life Sciences launches a high-performing, validated viral extraction solution

Beckman Coulter Life Sciences today announced the launch of RNAdvance Viral XP, a new RNA extraction kit validated for use in infectious disease and real-time PCR virus research. The kit is now available for purchase as high-throughput laboratories worldwide ramp up RNA extraction capabilities.

RNAdvance Viral XP is intended for use in high-throughput research workflows to extract viral RNA from swab samples, an essential step in the overall workflow. After RNA extraction, the collected RNA is used in qRT-PCR kits to test whether the RNA from a virus is present, yielding a positive or negative result.

The isolation of RNA from viral samples is a critical step in researching viruses and other deadly pathogens. Our development team has worked closely with global research partners during the past several months to provide customers with a high-performing, validated viral extraction solution during this time of increased need.”

Greg Milosevich, President, Beckman Coulter Life Sciences

Beckman Coulter Life Sciences worked with iRepertoire in Huntsville, Alabama to develop the reagent kit’s method. iRepertoire then independently validated the method. Both parties were pleased with the results.

We performed more than 100 RNA extractions and more than 500 qPCR reactions during a three-day period to validate RNAdvance Viral XP. The results clearly demonstrate this new solution from Beckman Coulter Life Sciences is a viable alternative to help alleviate a critical shortage in the RNA extraction kit supply chain.

Doing our part to support customers during a time of increased need is a priority for me and all Beckman Coulter Life Sciences associates as we build a robust supply chain, scale production and increase field support capabilities. We’re all in this together, and I’m confident our technology will expand the availability of extraction solutions for research laboratories around the world.”

Miranda L. Byrne-Steele, Ph.D., Director of Operations and R&D, iRepertoire

Beckman Coulter Life Sciences is an operating company within Danaher Corporation’s Life Sciences platform.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Beckman Coulter Life Sciences. (2020, May 18). Beckman Coulter Life Sciences launches a high-performing, validated viral extraction solution. News-Medical. Retrieved on December 08, 2024 from https://www.news-medical.net/news/20200518/Beckman-Coulter-Life-Sciences-launches-a-high-performing-validated-viral-extraction-solution.aspx.

  • MLA

    Beckman Coulter Life Sciences. "Beckman Coulter Life Sciences launches a high-performing, validated viral extraction solution". News-Medical. 08 December 2024. <https://www.news-medical.net/news/20200518/Beckman-Coulter-Life-Sciences-launches-a-high-performing-validated-viral-extraction-solution.aspx>.

  • Chicago

    Beckman Coulter Life Sciences. "Beckman Coulter Life Sciences launches a high-performing, validated viral extraction solution". News-Medical. https://www.news-medical.net/news/20200518/Beckman-Coulter-Life-Sciences-launches-a-high-performing-validated-viral-extraction-solution.aspx. (accessed December 08, 2024).

  • Harvard

    Beckman Coulter Life Sciences. 2020. Beckman Coulter Life Sciences launches a high-performing, validated viral extraction solution. News-Medical, viewed 08 December 2024, https://www.news-medical.net/news/20200518/Beckman-Coulter-Life-Sciences-launches-a-high-performing-validated-viral-extraction-solution.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline